Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
3619.65%
operating margin TTM
4380.77%
revenue TTM
7.40 Million
revenue per share TTM
0.36$
valuation ratios | |
|---|---|
| pe ratio | -1.02 |
| peg ratio | -0.04 |
| price to book ratio | 0.66 |
| price to sales ratio | -36.64 |
| enterprise value multiple | -1.18 |
| price fair value | 0.66 |
profitability ratios | |
|---|---|
| gross profit margin | 248.15% |
| operating profit margin | 4380.77% |
| pretax profit margin | 3663.23% |
| net profit margin | 3619.65% |
| return on assets | -40.15% |
| return on equity | -65.14% |
| return on capital employed | -55.1% |
liquidity ratio | |
|---|---|
| current ratio | 5.82 |
| quick ratio | 5.82 |
| cash ratio | 3.36 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 199.94 |
| cash conversion cycle | -199.94 |
| receivables turnover | 0.00 |
| payables turnover | 1.83 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.31 |
| debt equity ratio | 0.51 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.34 |
| interest coverage | -94.92 |
| cash flow to debt ratio | -1.17 |
cash flow ratios | |
|---|---|
| free cash flow per share | -4.13 |
| cash per share | 7.34 |
| operating cash flow per share | -4.10 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -1.17 |
| short term coverage ratios | -8.03 |
| capital expenditure coverage ratio | -164.97 |
Frequently Asked Questions
When was the last time Adverum Biotechnologies, Inc. (NASDAQ:ADVM) reported earnings?
Adverum Biotechnologies, Inc. (ADVM) published its most recent earnings results on 04-11-2024.
What is Adverum Biotechnologies, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Adverum Biotechnologies, Inc. (NASDAQ:ADVM)'s trailing twelve months ROE is -65.14%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Adverum Biotechnologies, Inc. (ADVM) currently has a ROA of -40.15%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ADVM's net profit margin stand at?
ADVM reported a profit margin of 3619.65% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ADVM's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.82 in the most recent quarter. The quick ratio stood at 5.82, with a Debt/Eq ratio of 0.51.